# LLM Judge Evaluation: tier1_004

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 0/2
- **Tool Use**: 1/2
- **Total**: 2/6

### Reasoning:
- Completion: The trace shows the descriptors workflow was submitted but never polled to completion: object_status remained 0 and completed_at is null. The agent ended with “I’ll check status in 10 seconds” and provided no descriptors or interpretation. Therefore the workflow did not finish and no results were presented.
- Correctness: No numerical descriptors were returned by the agent, so nothing can be validated against literature values (pKa, logP/logD, TPSA, solubility, etc.). By rubric, absence of a numerical result yields 0 for correctness.
- Tool use: The agent chose reasonable tools and a valid SMILES for psilocybin (CN(C)CCc1c[nH]c2cccc(O[P](O)(O)=O)c12), consistent with reference SMILES (CN(C)CCC1=CNC2=C1C(=CC=C2)OP(=O)(O)O). However, it failed to follow through with status polling and retrieval of computed descriptors, and did not interpret results. This is partial credit.

### Feedback:
- You submitted a valid SMILES and launched the descriptors workflow, but you did not poll for completion or return any descriptor values. Always poll the job to completion and report: MW, cLogP/logD7.4, TPSA, HBD/HBA, pKa set, rotatable bonds, and ionization/charge at pH 7.4, with brief CNS interpretation (e.g., BBB likelihood vs psilocin).
- Include at least one experimentally grounded value (e.g., pKa set) with citations, and compare your computed/predicted numbers to literature to demonstrate plausibility.
- For psilocybin specifically, note and discuss that phosphate-driven ionization reduces passive CNS penetration and that CNS exposure relies on in vivo dephosphorylation to psilocin; tie descriptors to that pharmacology.
- Literature validation: Because the agent returned no numerical descriptors, error analysis cannot be computed. For context, literature/predicted reference values for psilocybin include:
- pKa values: ~1.3 and ~6.5 (phosphate OHs), and ~10.4 (tertiary amine). Agent value: not provided. Absolute/percent error: N/A. Score justification: no numerical result provided → 0/2. Source: Wikipedia Psilocybin page (summarizing crystallography/chemistry sources). ([en.wikipedia.org](https://en.wikipedia.org/wiki/Psilocybin?utm_source=openai))
- logP (predicted): reports vary by method, e.g., ALOGPS ≈ 1.25 and ChemAxon ≈ −0.14. Agent value: not provided. Absolute/percent error: N/A. Score justification: no numerical result provided → 0/2. Source: DrugBank DB11664. ([go.drugbank.com](https://go.drugbank.com/drugs/DB11664?utm_source=openai))
- Topological polar surface area (TPSA): ≈85.8 Å² (predicted, ChemAxon). Agent value: not provided. Absolute/percent error: N/A. Score justification: no numerical result provided → 0/2. Source: DrugBank DB11664. ([go.drugbank.com](https://go.drugbank.com/drugs/DB11664?utm_source=openai))
- Hydrogen bond donors/acceptors: HBD ≈3, HBA ≈4 (predicted). Agent value: not provided. Absolute/percent error: N/A. Source: DrugBank DB11664. ([go.drugbank.com](https://go.drugbank.com/drugs/DB11664?utm_source=openai))
- Water solubility: reported qualitatively as high (zwitterionic phosphate); quantitative reports vary (e.g., 2.7 g/L predicted; experimental ranges near 0.1 mg/mL in certain media for related studies). Agent value: not provided. Absolute/percent error: N/A. Sources: DrugBank; review/experimental reports. ([go.drugbank.com](https://go.drugbank.com/drugs/DB11664?utm_source=openai))

Note on CNS-relevant thresholds: BBB penetration commonly correlates with TPSA < 90 Å²; psilocybin’s predicted TPSA (~86 Å²) is near this cutoff but its ionization state (net anionic/zwitterionic at pH 7.4) disfavors passive CNS entry relative to psilocin. Threshold reference: TPSA/BBB guidance. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Polar_surface_area?utm_source=openai))

### Web Search Citations:
1. [Psilocybin](https://en.wikipedia.org/wiki/Psilocybin?utm_source=openai)
2. [Psilocybin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB11664?utm_source=openai)
3. [Psilocybin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB11664?utm_source=openai)
4. [Psilocybin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB11664?utm_source=openai)
5. [Psilocybin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB11664?utm_source=openai)
6. [Polar surface area](https://en.wikipedia.org/wiki/Polar_surface_area?utm_source=openai)

### Execution:
- **Tools**: submit_descriptors_workflow, molecule_lookup
- **Time**: 0.4 min

---
*Evaluated with openai/gpt-5*
